[Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D008945:Mitral Valve Prolapse / Q000188:drug therapy* / Q000503:physiopathology; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol
Prolapso de válvula mitral. Avaliação da eficácia do nadolol no controle dos sintomas clínicos e na normalização dos traçados eletrocardiográficos.